LAUSR

REFERENCES 1. Specht K, Antonescu CR. Glomus tumour. In: WHO Classification of Tumours Editorial Board, ed. Soft Tissue and Bone Tumours. 5th ed. International Agency for Research on Cancer; 2020:179-181. 2. Folpe AL, Fanburg-Smith JC, Miettinen M, Weiss SW. Atypical and malignant glomus tumors: analysis of 52 cases, with a proposal for the reclassification of glomus tumors. Am J Surg Pathol. 2001;25(1):1-12. doi:10.1097/00000478-200101000-00001 3. Luzar B, Martin B, Fisher C, Calonje E. Cutaneous malignant glomus tumours: applicability of currently established malignancy criteria for tumours occurring in the skin. Pathology. 2018;50(7):711-717. doi:10. 1016/j.pathol.2018.08.005 4. Harada S, Caliò A, Janowski KM, et al. Diagnostic utility of one-stop fusion gene panel to detect TFE3/TFEB gene rearrangement and amplification in renal cell carcinomas. Mod Pathol. 2021;34(11):20552063. doi:10.1038/s41379-021-00858-y 5. Karamzadeh Dashti N, Bahrami A, Lee SJ, et al. BRAF V600E mutations occur in a subset of glomus tumors, and are associated with malignant histologic characteristics. Am J Surg Pathol. 2017;41(11):1532-1541. doi:10.1097/PAS.0000000000000913 6. Mosquera JM, Sboner A, Zhang L, et al. Novel MIR143-NOTCH fusions in benign and malignant glomus tumors. Genes Chromosomes Cancer. 2013;52(11):1075-1087. doi:10.1002/gcc.22102 7. Agaram NP, Zhang L, Jungbluth AA, Dickson BC, Antonescu CR. A molecular reappraisal of glomus tumors and related pericytic neoplasms with emphasis on NOTCH-gene fusions. Am J Surg Pathol. 2020;44(11): 1556-1562. doi:10.1097/PAS.0000000000001531 8. Cuviello A, Goyal A, Zick A, et al. Sporadic malignant glomus tumor of the brachial plexus with response to targeted therapy directed against oncogenic BRAF. JCO Precis Oncologia. 2018;2018:PO.17.00261. doi: 10.1200/PO.17.00261 9. Chakrapani A, Warrick A, Nelson D, Beadling C, Corless CL. BRAF and KRAS mutations in sporadic glomus tumors. Am J Dermatopathol. 2012;34(5):533-535. doi:10.1097/DAD.0b013e31823931b4